Literature DB >> 33496570

Caenorhabditis elegans Model Studies Show MPP+ Is a Simple Member of a Large Group of Related Potent Dopaminergic Toxins.

David Murphy1, Harshil Patel1, Kandatege Wimalasena1.   

Abstract

Although the causes of Parkinson's disease (PD) are not fully understood, the consensus is that a combination of genetic and environmental factors plays a major role. The discovery that the synthetic chemical, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-derived N-methyl-4-phenylpyridinium (MPP+), recapitulates major pathophysiological characteristics of PD in humans and other mammals has provided the strongest support for this possibility; however, several key aspects of the mechanism remain unclear. In contrast to the widely accepted view that MPP+ is structurally unique and optimal for selective dopaminergic toxicity, previous in vitro studies have suggested that MPP+ is most likely a simple member of a large group of related dopaminergic toxins. Here we provide first in vivo evidence to support the above possibility using Caenorhabditis elegans PD models. We also provide in vivo evidence to show that the inherent predisposition of dopaminergic neurons to produce high oxidative stress and related downstream effects when exposed to MPP+ and related mitochondrial toxins is responsible for their selective vulnerability to these toxins. More significantly, present findings suggest that if this broad group of MPP+ related dopaminergic toxins are present in work places or in the environment, they could cause far-reaching public health consequences.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33496570      PMCID: PMC8931847          DOI: 10.1021/acs.chemrestox.0c00422

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  56 in total

Review 1.  Epidemiology of Parkinson's disease.

Authors:  A Elbaz; L Carcaillon; S Kab; F Moisan
Journal:  Rev Neurol (Paris)       Date:  2015-12-21       Impact factor: 2.607

2.  J-aggregates: from serendipitous discovery to supramolecular engineering of functional dye materials.

Authors:  Frank Würthner; Theo E Kaiser; Chantu R Saha-Möller
Journal:  Angew Chem Int Ed Engl       Date:  2011-03-25       Impact factor: 15.336

3.  A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking.

Authors:  Richard Nass; Maureen K Hahn; Tammy Jessen; Paul W McDonald; Lucia Carvelli; Randy D Blakely
Journal:  J Neurochem       Date:  2005-06-30       Impact factor: 5.372

Review 4.  C. elegans as a model system to accelerate discovery for Parkinson disease.

Authors:  Bryan A Martinez; Kim A Caldwell; Guy A Caldwell
Journal:  Curr Opin Genet Dev       Date:  2017-02-24       Impact factor: 5.578

5.  A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay.

Authors:  Windy A Boyd; Sandra J McBride; Julie R Rice; Daniel W Snyder; Jonathan H Freedman
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-04       Impact factor: 4.219

6.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

Review 7.  Quaternary pyridinium salts: a review.

Authors:  Parag Madaan; Vinod K Tyagi
Journal:  J Oleo Sci       Date:  2008       Impact factor: 1.601

8.  Measurement of Reactive Oxygen Species (ROS) and Mitochondrial ROS in AMPK Knockout Mice Blood Vessels.

Authors:  Qilong Wang; Ming-Hui Zou
Journal:  Methods Mol Biol       Date:  2018

9.  Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP.

Authors:  Mapa S T Mapa; Viet Q Le; Kandatege Wimalasena
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

10.  An enhanced C. elegans based platform for toxicity assessment.

Authors:  Huajiang Xiong; Catherine Pears; Alison Woollard
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.